Clinical trial NCT00541164 - References

Charcot Marie Tooth Disease — Effects of Coenzyme Q10 on Charcot-Marie-Tooth Disease

Citation(s)

•   Beal MF
  Coenzyme Q10 as a possible treatment for neurodegenerative diseases. Free Radic Res. 2002 Apr;36(4):455-60. Review.
•   Bhagavan HN, Chopra RK
  Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res. 2006 May;40(5):445-53. Review.
•   Chaudhuri A, Behan PO
  Fatigue in neurological disorders. Lancet. 2004 Mar 20;363(9413):978-88. Review.
•   Hendler SS, Rorvik D, eds
  PDR for Nutritional Supplements. Montvale, NJ: Thomson PDR; 2001:105-106.
•   Huntington Study Group
  A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease. Neurology. 2001 Aug 14;57(3):397-404.
•   Jones K, Hughes K, Mischley L, McKenna DJ
  Coenzyme Q-10: efficacy, safety, and use. Altern Ther Health Med. 2002 May-Jun;8(3):42-55; quiz 56, 138. Review.
•   Lagendijk J, Ubbink JB, Vermaak WJ
  Measurement of the ratio between the reduced and oxidized forms of coenzyme Q10 in human plasma as a possible marker of oxidative stress. J Lipid Res. 1996 Jan;37(1):67-75.
•   Shults CW, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S, Juncos JL, Nutt J, Shoulson I, Carter J, Kompoliti K, Perlmutter JS, Reich S, Stern M, Watts RL, Kurlan R, Molho E, Harrison M, Lew M; Parkinson Study Group
  Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol. 2002 Oct;59(10):1541-50.
•   Shults CW
  Coenzyme Q10 in neurodegenerative diseases. Curr Med Chem. 2003 Oct;10(19):1917-21. Review.

Effects of Coenzyme Q10 (CoQ10) on Subjects With Charcot-Marie-Tooth Disease (CMT):A Double Blind, Randomized, Controlled Trial With an Open Label Follow-up Study

Details for clinical trial NCT00541164